Antidiabetic compounds, any
32456064 2020. Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis.
32382358 ä. COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher?s Stone?
32388906 2020. Do novel drugs for diabetes help in COVID-19? Another brick in the wall?
32495299 2020. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
32313883 2020. Inhaled biguanides and mTOR inhibition for influenza and coronavirus (Review)
32347974 2020. Metformin and COVID-19: A novel deal of an Old Drug
32533990 2020. Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
32446796 2020. Metformin, neutrophils and COVID-19 infection.
32470199 2020. Metformin use amid coronavirus disease 2019 pandemic.
32360697 2020. Metformin in COVID-19: A possible role beyond diabetes.
32339534 2020. COVID-19 and diabetes: Is metformin a friend or foe?
32463794 2020. Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19.
32446312 2020. Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis.
32592841 2020. A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19.
32506195 2020. Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19.
32333972 ä. Letter to the Editor in response to the article ?COVID-19 and diabetes: Can DPP4 inhibition play a role??
32333966 2020. COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications
32333969 ä. Response to COVID -19 and Diabetes: Can DPP4 Inhibition Play a Role? ? GLP-1 Might Play One Too
32283128 ä. Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? on ace2 via adam17, nfkb via dpp4
32061923 2020. Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions
32349031 2020. Role of Dipeptidyl Peptidase 4 Inhibitors in Diabetic Patients with Coronavirus-19 Infection
32336007 2020. DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19?
32224164 2020. COVID-19 and diabetes: Can DPP4 inhibition play a role?
32335097 2020. SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?
32416120 2020. Is DPP4 inhibition a comrade or adversary in COVID-19 infection.
32592113 2020. Potential role of incretins in diabetes and COVID-19 infection: a hypothesis worth exploring.
32534505 2020. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
32335366 2020. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis
32447736 2020. Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends.
32493609 2020. SGLT-2 inhibitors for COVID-19 - A miracle waiting to happen or just another beat around the bush?
32562762 2020. SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?
32605278 2020. Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19.
32344313 ä. Can pioglitazone be potentially useful therapeutically in treating patients with covid-19?
32365556 2020. Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-gamma as Candidates for Cytokine Storm Modulation in COVID-19 Disease
32540737 2020. Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
alpha glucosidase inh war das mal acarbose kine ahnung
32510142 2020. alpha-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19.
32562701 2020. Apelin-potential therapy for COVID-19?
32593740 2020. Irisin modulates genes associated with severe coronavirus disease (COVID-19) outcome in human subcutaneous adipocytes.
32334392 2020. Enhancing immunity in viral infections, with special emphasis on COVID-19: A review.
32234504 2020. COVID-19, diabetes mellitus and ACE2: The conundrum.